These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 21825240
1. Resting tremor in Parkinson disease: a negative predictor of levodopa-induced dyskinesia. Kipfer S, Stephan MA, Schüpbach WM, Ballinari P, Kaelin-Lang A. Arch Neurol; 2011 Aug; 68(8):1037-9. PubMed ID: 21825240 [Abstract] [Full Text] [Related]
2. The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia. Zhang YH, Tang BS, Song CY, Xu Q, Lou MX, Liu ZH, Yu RH, Yan XX, Guo JF. Neurosci Lett; 2013 Nov 27; 556():109-12. PubMed ID: 24135335 [Abstract] [Full Text] [Related]
3. Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease. Nicoletti A, Mostile G, Nicoletti G, Arabia G, Iliceto G, Lamberti P, Marconi R, Morgante L, Barone P, Quattrone A, Zappia M. J Neurol; 2016 May 27; 263(5):888-894. PubMed ID: 26964541 [Abstract] [Full Text] [Related]
4. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Zappia M, Annesi G, Nicoletti G, Arabia G, Annesi F, Messina D, Pugliese P, Spadafora P, Tarantino P, Carrideo S, Civitelli D, De Marco EV, Cirò-Candiano IC, Gambardella A, Quattrone A. Arch Neurol; 2005 Apr 27; 62(4):601-5. PubMed ID: 15824260 [Abstract] [Full Text] [Related]
6. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease. Lin JJ, Yueh KC, Lin SZ, Harn HJ, Liu JT. J Neurol Sci; 2007 Jan 31; 252(2):130-4. PubMed ID: 17196621 [Abstract] [Full Text] [Related]
14. A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy. Benbir G, Ozekmekçi S, Apaydin H, Delil S, Erginöz E. Clin Neurol Neurosurg; 2006 Dec 31; 108(8):726-32. PubMed ID: 16564615 [Abstract] [Full Text] [Related]
16. Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease. Hong JY, Oh JS, Lee I, Sunwoo MK, Ham JH, Lee JE, Sohn YH, Kim JS, Lee PH. Neurology; 2014 May 06; 82(18):1597-604. PubMed ID: 24719485 [Abstract] [Full Text] [Related]
18. Levodopa induced motor complications in Thai Parkinson's disease patients. Kulkantrakorn K, Tiamkao S, Pongchaiyakul C, Pulkes T. J Med Assoc Thai; 2006 May 06; 89(5):632-7. PubMed ID: 16756048 [Abstract] [Full Text] [Related]
19. Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE. Mov Disord; 2005 Mar 06; 20(3):342-4. PubMed ID: 15580606 [Abstract] [Full Text] [Related]
20. Intra- and inter-limb coherency during stance in non-dyskinetic and dyskinetic patients with Parkinson's disease. Mann RK, Edwards R, Zhou J, Jog M, Duval C. Clin Neurol Neurosurg; 2010 Jun 06; 112(5):392-9. PubMed ID: 20206438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]